High cholesterol levels are considered to be a risk factor for cardiovascular disease including stroke. Therefore, many cholesterol lowering drugs have been developed by pharmaceutical companies in recent years. One class of these drugs, statins, has been found to reduce the incidence of stroke and progression of Alzheimer’s disease when prophylactically administered.
Related stories:
Structure of key epigenetics component identified
Scientists from the Structural Genomics Consortium (SGC) have determined the 3D structure of a key protein component involved in enabling "epigenetic code" to be copied accurately from cell to cell.
New stem cell tools to aid drug development
SCIENTISTS have designed, developed and tested new molecular tools for stem cell research to direct the formation of certain tissue types for use in drug development programmes.
Researchers piece together gene 'network' linked to schizophrenia
Reporting this week in the Archives of General Psychiatry, researchers at the Johns Hopkins University School of Medicine have uncovered for the first time molecular circuitry associated with schizophrenia that links three previously known, yet unrelated proteins.
Growing new ear hairs that can boost hearing: study
Scientists have used gene therapy on mouse embryos to grow hair cells with the potential to reduce hearing loss in adult animals, according to a study released Wednesday.
Scientists nail childhood nerve cancer gene
Researchers have identified the hereditary gene mutations behind a deadly form of childhood cancer, opening the way to genetic tests in high-risk families, according to study released Sunday.
Face transplant patient can smile, blink again
(AP) -- Transplanting faces may seem like science fiction, but doctors say the experimental surgeries could one day become routine. Two of the world's three teams that have done partial face transplants reported Friday that their techniques were surprisingly effective, though complications exist and more work is still needed.
Coatings to help medical implants connect with neurons
Plastic coatings could someday help neural implants treat conditions as diverse as Parkinson's disease and macular degeneration.
Study finds way to prevent protein clumping characteristic of Parkinson's disease
Researchers at the University of Pennsylvania School of Medicine have identified a protein from a most unlikely source -- baker's yeast -- that might protect against Parkinson's disease. More than a million Americans suffer from Parkinson's disease, and no treatments are available that fundamentally alter the course of the condition. By introducing the yeast protein Hsp104 into animal models of Parkinson's disease, researchers prevented protein clumping that leads to nerve cell death characteristic of the disorder.